EGFR mutations and molecularly targeted therapy: A new era in the treatment of lung cancer

Research output: Contribution to journalArticle

13 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)170-171
Number of pages2
JournalNature Clinical Practice Oncology
Volume3
Issue number4
DOIs
StatePublished - Apr 2006

Fingerprint

Quinazolines
erbB-1 Genes
Gene Dosage
Drug Delivery Systems
Protein Kinase Inhibitors
Epidermal Growth Factor Receptor
Non-Small Cell Lung Carcinoma
Lung Neoplasms
Clinical Trials
Mutation
Therapeutics

ASJC Scopus subject areas

  • Oncology

Cite this

@article{bcf08bffadb349879ce3e85b34ad94cc,
title = "EGFR mutations and molecularly targeted therapy: A new era in the treatment of lung cancer",
author = "Dowell, {Jonathan E.} and Minna, {John D.}",
year = "2006",
month = "4",
doi = "10.1038/ncponc0476",
language = "English (US)",
volume = "3",
pages = "170--171",
journal = "Nature Reviews Clinical Oncology",
issn = "1759-4774",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - EGFR mutations and molecularly targeted therapy

T2 - A new era in the treatment of lung cancer

AU - Dowell, Jonathan E.

AU - Minna, John D.

PY - 2006/4

Y1 - 2006/4

UR - http://www.scopus.com/inward/record.url?scp=33645709473&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645709473&partnerID=8YFLogxK

U2 - 10.1038/ncponc0476

DO - 10.1038/ncponc0476

M3 - Article

C2 - 16596125

AN - SCOPUS:33645709473

VL - 3

SP - 170

EP - 171

JO - Nature Reviews Clinical Oncology

JF - Nature Reviews Clinical Oncology

SN - 1759-4774

IS - 4

ER -